Celadon gets nod to start cannabis trial for pain in UK

Celadon Pharmaceuticals has secured the final approval needed to start a large-scale trial of its cannabinoid therapy for chronic pain in the UK. The AIM-listed company said this morning that the NHS Research Ethics Committee had given the green light for the study in up to 5,000 non-cancer pain patients to get underway after it […]

Go to Source

Powered by WPeMatico